Pfizer Raises 2026 Forecast After Third-Quarter Results Beat Estimates
Pfizer lifted its revenue and adjusted-profit outlook after quarterly sales and adjusted earnings exceeded analyst expectations.
Makkler Newsroom · Nov 3, 03:22 PM · 1 min read
Pfizer Inc. PFE
NYSEHealth TechnologyUnited States
$28.89+0.06 (+0.21%)
Market closed· · USD · Data may be delayed
- Day's range
- 28.6228.99
- 52-week range
- 23.6231.44
Financial health
– / 5
Analyst view · 28 firms
Hold8 buy · 17 hold · 3 sell
Avg. target $29.92 (+3.6%)
Prices may be delayed and are for informational purposes only - not investment advice.